WO2000014537A3 - Immunoconjugate for diagnosis of multidrug resistance - Google Patents

Immunoconjugate for diagnosis of multidrug resistance

Info

Publication number
WO2000014537A3
WO2000014537A3 PCT/US1999/020017 US9920017W WO2000014537A3 WO 2000014537 A3 WO2000014537 A3 WO 2000014537A3 US 9920017 W US9920017 W US 9920017W WO 2000014537 A3 WO2000014537 A3 WO 2000014537A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
multidrug resistant
immunoconjugate
diagnosis
multidrug
immunoconjugates
Prior art date
Application number
PCT/US1999/020017
Other languages
French (fr)
Other versions
WO2000014537A2 (en )
Inventor
David M Goldenberg
Original Assignee
Immunomedics Inc
David M Goldenberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody conjugates with carriers being antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody

Abstract

Immunoconjugates of a diagnostic agent and an antibody component that binds an epitope of a multidrug transporter protein are disclosed. Thesse immunoconjugates are used in in vivo diagnostic methods to determine whether the failure of traditional chemotherapy is due to the presence of multidrug resistant tumor cells, multidrug resistant HIV-infected cells or multidrug resistant infectious agents.
PCT/US1999/020017 1998-09-04 1999-09-01 Immunoconjugate for diagnosis of multidrug resistance WO2000014537A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US9930498 true 1998-09-04 1998-09-04
US60/099,304 1998-09-04

Publications (2)

Publication Number Publication Date
WO2000014537A2 true WO2000014537A2 (en) 2000-03-16
WO2000014537A3 true true WO2000014537A3 (en) 2000-07-20

Family

ID=22274363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/020017 WO2000014537A3 (en) 1998-09-04 1999-09-01 Immunoconjugate for diagnosis of multidrug resistance

Country Status (1)

Country Link
WO (1) WO2000014537A3 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008802A1 (en) * 1990-10-29 1992-05-29 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
WO1993002105A1 (en) * 1991-07-19 1993-02-04 Hybritech Incorporated Trifunctional compounds having specificity for multi-drug resistant cells
WO1993019094A1 (en) * 1992-03-20 1993-09-30 Board Of Trustees Of The University Of Illinois A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
WO1993025700A1 (en) * 1992-06-17 1993-12-23 Istituto Superiore Di Sanita' Monoclonal antibodies to glycoprotein p
WO1996004313A1 (en) * 1994-08-05 1996-02-15 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008802A1 (en) * 1990-10-29 1992-05-29 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
WO1993002105A1 (en) * 1991-07-19 1993-02-04 Hybritech Incorporated Trifunctional compounds having specificity for multi-drug resistant cells
WO1993019094A1 (en) * 1992-03-20 1993-09-30 Board Of Trustees Of The University Of Illinois A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
WO1993025700A1 (en) * 1992-06-17 1993-12-23 Istituto Superiore Di Sanita' Monoclonal antibodies to glycoprotein p
WO1996004313A1 (en) * 1994-08-05 1996-02-15 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KARTNER N. ET AL: "Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies", NATURE, vol. 316, no. 29, August 1985 (1985-08-01), pages 820 - 823, XP000857277 *

Also Published As

Publication number Publication date Type
WO2000014537A2 (en) 2000-03-16 application

Similar Documents

Publication Publication Date Title
Byers et al. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer
Paronetto et al. Immunocytochemical observations in periarteritis nodosa
USRE38008E1 (en) Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
Yorde et al. Competitive enzyme-liked immunoassay with use of soluble enzyme/antibody immune complexes for labeling. I. Measurement of human choriogonadotropin.
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
WO2004022717A3 (en) Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen
Milenic et al. Comparison of methods for the generation of immunoreactive fragments of a monoclonal antibody (B72. 3) reactive with human carcinomas
WO2003016466A3 (en) ANTI-Aβ ANTIBODIES
FRÖDIN et al. Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomas
CA2019559A1 (en) Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof
de Heer et al. Possible involvement of terminal complement complex in active Heymann nephritis
DE29818551U1 (en) Valve, in particular double-seat valve leakage
Partridge et al. The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG
CA2272245A1 (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
Bickel et al. Development and in vitro characterization of a cationized monoclonal antibody against βA4 protein: a potential probe for Alzheimer's disease
Bellucci et al. Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with anagrelide
Marshall et al. Galactosylated streptavidin for improved clearance of biotinylated intact and F (ab') 2 fragments of an anti-tumour antibody
GB2246570A (en) Humanised antibodies
DE20105223U1 (en) Butt joint of frame parts, in particular post and rail connection
Marchalonis et al. Visualization of a guinea pig T lymphocyte surface component cross-reactive with immunoglobulin
DE29816367U1 (en) Channel inspection and refurbishment vehicle
WO2002079232A3 (en) Reducing the immunogenicity of fusion proteins
Porstmann et al. Comparison of monoclonal and polyclonal antibodies in a two-site binding enzyme immunoassay for alphafetoprotein (AFP)
Gadina et al. Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18
Zara et al. Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase